Pretty strong presentation,
From what I gather half of the $550 million from CSL is in the form of developmental milestone payments that MNTA will be eligible to receive regardless of whether they opt in to co-develop M230.
The other half, in the form of commercial milestone payments, they will forego should they choose to opt in.
Does having multiple partners (Sandoz, CSL, Mylan, possibly a 4th for M923) complicate a buyout?
Market Data 
Markets 
AI
